Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

被引:85
作者
Vander Cruyssen, B [1 ]
Hoffman, IEA [1 ]
Zmierczak, H [1 ]
Van den Berghe, M [1 ]
Kruithof, E [1 ]
De Rycke, L [1 ]
Mielants, H [1 ]
Veys, EM [1 ]
Baeten, D [1 ]
De Keyser, F [1 ]
机构
[1] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium
关键词
D O I
10.1136/ard.2004.032177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anti-cyclic citrullinated peptide (anti-CCP) antibodies are considered highly specific markers of rheumatoid arthritis. Despite the high specificity of the test, anti-CCP antibodies have also been observed in psoriatic arthritis. Objective: To determine the frequency of anti-CCP antibodies in psoriatic arthritis and to describe the clinical characteristics of such patients. Methods: Serum samples from 192 patients with psoriatic arthritis were analysed for anti-CCP antibodies. A previously defined cut off point was applied at a specificity level of >= 98.5% (42 U/ml). Antibodies against pepA and pepB (two synthetic citrullinated peptides) were determined on samples containing anti-CCP antibodies by line immune assay. The swollen joint count and the numbers of affected joints (present or past) were recorded. Clinical features were noted and if available radiographs of hands and feet were scored for erosions. Rheumatoid factor was determined in all samples. Results: Anti-CCP antibodies were found in 15 patients (7.8%); 13 of 15 anti-CCP2 positive samples were also positive for anti-pepA or pepB antibodies. The prevalence of anti-CCP antibodies was higher than expected in view of the highly specific cut off applied in the test. Detailed analysis of the clinical and radiological features makes it improbable that the high prevalence of anti-CCP antibodies resulted solely from concomitant psoriasis and rheumatoid arthritis or from misclassification. Conclusions: Anti-CCP antibodies may be present in patients with psoriatic arthritis. Although some of the present cohort could have had psoriasis with concomitant rheumatoid arthritis, a proportion at least had the typical characteristics of psoriatic arthritis as the primary diagnosis.
引用
收藏
页码:1145 / 1149
页数:5
相关论文
共 35 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis [J].
Berglin, E ;
Padyukov, L ;
Sundin, U ;
Hallmans, G ;
Stenlund, H ;
van Venrooij, WJ ;
Klareskog, L ;
Dahlqvist, SR .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) :R303-R308
[3]   Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations [J].
De Rycke, L ;
Peene, I ;
Hoffman, IEA ;
Kruithof, E ;
Union, A ;
Meheus, L ;
Lebeer, K ;
Wyns, B ;
Vincent, C ;
Mielants, H ;
Boullart, L ;
Serre, G ;
Veys, EM ;
De Keyser, F .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) :1587-1593
[4]   THE EUROPEAN-SPONDYLARTHROPATHY-STUDY-GROUP PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SPONDYLARTHROPATHY [J].
DOUGADOS, M ;
VANDERLINDEN, S ;
JUHLIN, R ;
HUITFELDT, B ;
AMOR, B ;
CALIN, A ;
CATS, A ;
DIJKMANS, B ;
OLIVIERI, I ;
PASERO, G ;
VEYS, E ;
ZEIDLER, H .
ARTHRITIS AND RHEUMATISM, 1991, 34 (10) :1218-1227
[5]   Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases [J].
Dubucquoi, S ;
Solau-Gervais, E ;
Lefranc, D ;
Marguerie, L ;
Sibilia, J ;
Goetz, J ;
Dutoit, V ;
Fauchais, AL ;
Hachulla, E ;
Flipo, RM ;
Prin, L .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (04) :415-419
[6]  
FOURNIE B, 1999, REV RHUM, V66, P513
[7]  
Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585
[8]   Assessment of patients with psoriatic arthritis - A review of currently available measures [J].
Gladman, DD ;
Helliwell, P ;
Mease, PJ ;
Nash, P ;
Ritchlin, C ;
Taylor, W .
ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :24-35
[9]  
GOTTENBERG J, 2004, ANN RHEUM DIS
[10]   Reporting of precision of estimates for diagnostic accuracy: a review [J].
Harper, R ;
Reeves, B .
BRITISH MEDICAL JOURNAL, 1999, 318 (7194) :1322-1323